Skip to content

Use of Biodesign® Otologic Graft in Tympanoplasty

Use of Biodesign® Otologic Graft in Tympanoplasty: A Prospective, Randomized Trial

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03904316
Enrollment
0
Registered
2019-04-05
Start date
2018-10-03
Completion date
2022-07-01
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tympanic Membrane Perforation

Brief summary

This is a prospective, randomized trial to evaluate tympanoplasty outcomes using Biodesign SIS graft compared to autologous temporalis fascia, the most commonly used graft for repair of tympanic membrane.

Detailed description

Patients 18 years or older will undergo primary tympanoplasty without mastoidectomy. The patients will be randomized into groups receiving Biodesign versus autograft temporalis fascia for repair.

Interventions

Acellular matrix derived from porcine small intestine submucosa

OTHERAutologous temporalis fascia

An autologous graft for tympanic membrane repair

Sponsors

Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing primary tympanoplasty without mastoidectomy.

Exclusion criteria

* Patients with a known biologic sensitivity or a cultural objection to use of porcine materials.

Design outcomes

Primary

MeasureTime frameDescription
Assessment of graft take after tympanoplasty1 month postoperatively by the surgeonMicroscopically evaluate tympanic membrane for perforation closure

Secondary

MeasureTime frameDescription
Measurement of Hearing ParametersMeasure hearing parameters preoperativelyTest the pure tone conduction (average of 500, 1000 and 2000 Hz).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026